SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-060466
Filing Date
2011-11-03
Accepted
2011-11-03 12:48:02
Documents
12
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-25795_110q.htm 10-Q 879062
2 EX-10.2 a11-25795_1ex10d2.htm EX-10.2 84298
3 EX-10.3 a11-25795_1ex10d3.htm EX-10.3 41270
4 EX-31.1 a11-25795_1ex31d1.htm EX-31.1 12313
5 EX-31.2 a11-25795_1ex31d2.htm EX-31.2 12954
6 EX-32.1 a11-25795_1ex32d1.htm EX-32.1 8740
  Complete submission text file 0001104659-11-060466.txt   3259916

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cldx-20110930.xml EX-101.INS 430426
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldx-20110930.xsd EX-101.SCH 12095
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldx-20110930_cal.xml EX-101.CAL 38131
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cldx-20110930_lab.xml EX-101.LAB 198430
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldx-20110930_pre.xml EX-101.PRE 97774
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldx-20110930_def.xml EX-101.DEF 62932
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 111176933
SIC: 2835 In Vitro & In Vivo Diagnostic Substances